Chronic Hepatitis
Links shared publicly online about this topic
Treatment For Chronic Hepatitis C: A Phase II Study
medicalnewstoday.com — “The current standard treatment for chronic hepatitis C with pegylated-interferon (PEG-IFN) and ribavirin is effective in approximately 50%-60% of patients, so that a substantial proportion of pati” View full resource at medicalnewstoday.com
Most Recently Shared on January 18, 2010 at 2:13 pm By:
Treatment For Chronic Hepatitis C: A Phase II Study http://mnt.to/3wrN
Viusid - A Nutritional Supplement For Treating Chronic Hepatitis C
medicalnewstoday.com — “The pathogenesis of chronic hepatitis C (CHC) is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis.” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2010 at 12:10 pm By:
Viusid - A Nutritional Supplement For Treating Chronic Hepatitis C http://mnt.to/3F2X #liver #hepatitis
Treatment of Chronic Hepatitis B Virus Infection | Gastroenterology
touchgastroenterology.com — “Treatment of Chronic Hepatitis B Virus Infection” View full resource at touchgastroenterology.com
Most Recently Shared on June 10, 2011 at 11:57 am By:
Treatment of Chronic Hepatitis B Virus Infection http://touchgastroenterology.com/articles/treatment-chronic-hepatitis-b-virus-infection
Advances in the Treatment of Chronic Hepatitis B | Gastroenterology
touchgastroenterology.com — “Treating chronic hepatitis B (CHB) is far more complex compared with dealing with chronic hepatitis C (CHC). In the latter, treatment for one year with pegylated interferons and ribavirin is the standard, and the search for new treatment modalities goes” View full resource at touchgastroenterology.com
Most Recently Shared on July 1, 2011 at 11:53 am By:
Advances in the Treatment of Chronic Hepatitis B http://www.touchgastroenterology.com/articles/advances-treatment-chronic-hepatitis-b
Victrelis Approved for Chronic Hepatitis C --Doctors Lounge
doctorslounge.com — “Victrelis Approved for Chronic Hepatitis C --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on May 16, 2011 at 9:10 pm By:
Victrelis Approved for Chronic Hepatitis C: In combination with two other drugs http://bit.ly/msx4QE
A nutritional supplement for treating chronic hepatitis C: Viusid
physorg.com — “A research team from Cuba investigated the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C. Their results showed that treatment with Viusid leads to a notable improvement of oxidative stress and immunological parameters in such ...” View full resource at physorg.com
Most Recently Shared on June 17, 2010 at 2:20 pm By:
A nutritional supplement for treating chronic hepatitis C: Viusid http://tw.physorg.com/195986126
Victrelis Approved for Chronic Hepatitis C - ONA
oncologynurseadvisor.com — “Merck announced that the FDA has approved Victrelis (boceprevir), a hepatitis C virus protease inhibitor, for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients 18 years of age with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 16, 2011 at 3:14 pm By:
Victrelis Approved for Chronic Hepatitis C http://goo.gl/fb/Sjo2D
Are Autoantibodies Relevant in Chronic Hepatitis C Infection? | Gastroenterology
touchgastroenterology.com — “Hepatitis C, autoantibodies, antinuclear antibody, antismooth muscle antibody, antiviral therapy” View full resource at touchgastroenterology.com
Most Recently Shared on July 8, 2011 at 11:52 am By:
Are Autoantibodies Relevant in Chronic Hepatitis C Infection? http://bit.ly/r2BG4g
Victrelis Approved for Chronic Hepatitis C - MPR
empr.com — “Merck announced that the FDA has approved Victrelis (boceprevir), a hepatitis C virus protease inhibitor, for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients 18 years of age with compensated liver disease, including cirrhosis, who are previously untreated or who have failed previous interferon and ribavirin therapy.” View full resource at empr.com
Most Recently Shared on May 16, 2011 at 3:31 pm By:
MPR News: Victrelis Approved for Chronic Hepatitis C: Merck announced that the FDA has approved Victrelis (bocep... http://bit.ly/j1wL3a
Boceprevir and telaprevir for the treatment of chronic hepatitis C gen
dovepress.com — “Peer reviewed article authored by (Cooper CL, Druyts E, Thorlund K, Nachega JB, El Khoury AC, O'Regan C, Mills EJ). Read article or submit your manuscript for publishing.” View full resource at dovepress.com
Most Recently Shared on March 27, 2012 at 4:32 pm By:
Boceprevir and telaprevir hepatitis C genotype 1:an indirect comparison meta-analysishttp://www.dovepress.com/articles.php?article_id=9446
In chronic hepatitis, liver inflammation continues for at least six months. Learn more about chronic hepatitis.
intelihealth.com — “In chronic hepatitis, liver inflammation continues for at least six months. Learn more about chronic hepatitis.” View full resource at intelihealth.com
Most Recently Shared on June 7, 2010 at 9:31 pm By:
In chronic hepatitis, liver inflammation continues for at least six months. Learn more about chronic hepatitis. http://bit.ly/daZ4k7
Elevated Lymphotoxin Expression In Liver Leads To Chronic Hepatitis And Causes HCC
medicalnewstoday.com — “A recent study maps the pathway that leads from infection with hepatitis b and c virus (hbv and hcv) to chronic hepatitis and liver cancer and proposes a new therapeutic strategy for treating live” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2009 at 5:43 pm By:
Elevated Lymphotoxin Expression In Liver Leads To Chronic Hepatitis And Causes HCC: A recent study maps the pat.. http://bit.ly/Oefik
Pharmasset Announces The Expansion Of The ELECTRON Trial In Chronic Hepatitis C
medicalnewstoday.com — “Pharmasset, Inc. (Nasdaq: VRUS) announced the addition of three treatment cohorts to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatiti” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 8:05 am By:
Pharmasset Announces The Expansion Of The ELECTRON Trial In Chronic Hepatitis C http://mnt.to/3WXr #liver #hepatitis
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)
theannals.com — “Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)” View full resource at theannals.com
Most Recently Shared on August 10, 2011 at 4:57 am By:
Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September): OBJECTIVE:To review the p... http://bit.ly/rrZDSP
Abstract | Should chronic hepatitis B mothers breastfeed? A meta analysis
biomedcentral.com — “A meta-analysis of the literature indicates that breastfeeding by mothers with chronic hepatitis B (CHB) is not associated with a demonstrable risk of infantile CHB infection, provided the infants have been vaccinated against HBV at birth.” View full resource at biomedcentral.com
Most Recently Shared on June 29, 2011 at 9:40 am By:
Should chronic #Hepatitis B mothers breastfeed? A Meta Analysis http://ht.ly/5rKli #HBV
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Liver Disease
The latest liver disease / hepatitis news published daily. Articles from research centers, universities and prestigious journals.
-
touchGASTRO
Touch GASTROENTEROLOGY is a medical journal informing professions about the latest advances. Including fighting Ulcerative colitis & fields such as Rheumatology
Advertisement

